VanEck Pharmaceutical ETF
PPH
#1332
ETF rank
$1.09 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
$119.33
Share price
2.06%
Change (1 day)
29.21%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of October 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of October 2026: 0.36%